Hims & Hers Health (HIMS) Profit After Tax (2019 - 2026)
Hims & Hers Health (HIMS) reported Profit After Tax of -$6.7 million for Q1 2026, down 4286.88% on a YoY basis from $160000.0 in Q1 2025, and down 132.52% sequentially from $20.6 million in Q4 2025.
Hims & Hers Health (HIMS) Profit After Tax (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Profit After Tax data on file, last reported at -$6.7 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 4286.88% year-over-year to -$6.7 million; the trailing twelve-month figure through Mar 2026 stood at $30.8 million (up 131.27% YoY), and the FY2025 full-year result was $128.4 million, up 64282.5% from the prior year.
- Profit After Tax fell to -$6.7 million in Q1 2026, from $20.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $54.6 million in Q4 2022 to a low of -$19.7 million in Q2 2022.
- A 5-year average of $2.4 million and a median of $166000.0 in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax sank 156850.0% in 2022 and surged 6603.61% in 2024, its largest moves.
- Tracing HIMS's Profit After Tax over 5 years: stood at $54.6 million in 2022, then tumbled by 97.98% to $1.1 million in 2023, then plunged by 150.23% to -$553000.0 in 2024, then jumped by 3825.32% to $20.6 million in 2025, then slumped by 132.52% to -$6.7 million in 2026.
- Business Quant data shows HIMS's Profit After Tax at -$6.7 million in Q1 2026, $20.6 million in Q4 2025, and $15.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -6.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.70 Mn |
| Dec 31, 2025 | 20.60 Mn |
| Sep 30, 2025 | 15.87 Mn |
| Jun 30, 2025 | 986,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Dec 31, 2024 | -553,000.00 |
| Sep 30, 2024 | 397,000.00 |
| Jun 30, 2024 | 13.30 Mn |
| Mar 31, 2024 | 11.13 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | -7.57 Mn |
| Jun 30, 2023 | -7.16 Mn |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 54.63 Mn |
| Sep 30, 2022 | -18.83 Mn |
| Jun 30, 2022 | -19.68 Mn |
| Mar 31, 2022 | -16.25 Mn |
| Dec 31, 2021 | 76.37 Mn |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -9.15 Mn |